Session Title: A Personalized Approach to Managing Patients with Uncontrolled Asthma
Faculty Presenter: Sandra Adams, MD, MS, Professor of Medicine, The University of Texas Health Science Center, San Antonio, TX
- Explain mechanisms of action (MOAs) for approved and emerging monoclonal antibodies, as well as rationale for choices based on phenotype
- Summarize key efficacy and safety data pertaining to the monoclonal antibodies studied for use in asthma
- Use monoclonal antibodies safely and appropriately in clinical scenarios
Location: Maggiano’s Little Italy Restaurant, 516 N. Clark St., Chicago, IL 60654
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Respiratory Health Association. The France Foundation is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ and 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Respiratory Health Association is offering 1.0 hour of continuing education for Respiratory Care Practitioners (RCPs). Respiratory Health Association is an approved continuing education sponsor recognized by the State of Illinois Department of Financial and Professional Regulation.
This educational activity is supported by an educational grant from GlaxoSmithKline.
For questions, contact Amy O’Rourke at [email protected] or 312-628-0217.
To view the online training for the previous session, Achieving Better Control of Severe Asthma: New Understandings in Asthma Pathophysiology and Targeted Therapies, click here.